Skip to main content
logo
Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.050
-0.050 (-2.38%)
Sep 3, 2026, 4:00 PM EDT - Market closed

Processa Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13.44-13.56-11.85-11.12-27.42-11.43
Depreciation & Amortization
00000.790.79
Other Amortization
----0.12-
Asset Writedown & Restructuring Costs
----7.270.3
Stock-Based Compensation
0.610.860.631.068.833.41
Other Operating Activities
0.72-0.220.091.390.27-0.61
Change in Accounts Receivable
----0.070.01
Change in Accounts Payable
0.870.180.57-0.020.11-0.1
Change in Other Net Operating Assets
-0.741.37-0.680.620.36-1.08
Operating Cash Flow
-11.97-11.39-11.25-8.06-9.61-8.72
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0-0--
Other Investing Activities
-1.16-0.85----
Investing Cash Flow
-1.16-0.85-0-0--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.01-0.01---
Net Debt Issued (Repaid)
-0-0.01-0.01---
Issuance of Common Stock
6.416.67.766.32-10.05
Repurchase of Common Stock
-0-0.01-0.02-0.05-0.39-0.06
Other Financing Activities
------0.19
Financing Cash Flow
6.416.587.736.27-0.399.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-6.744.35-3.51-1.8-9.991.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.97-11.39-11.25-8.07-9.61-8.72
Free Cash Flow Growth
------
Free Cash Flow Per Share
-4.98-8.70-91.87-153.75-298.12-284.52
Levered Free Cash Flow
-8.74-6.55-5.85-4.11-2.96-4.19
Unlevered Free Cash Flow
-8.74-6.55-5.85-4.11-3.08-4.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.010.010---
Change in Working Capital
0.131.54-0.110.610.54-1.18
SEC Filings: 10-K · 10-Q